Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII.
Fibrin polymers (des A,B fibrinogen) reduced the concentration of alpha-thrombin required for 50% activation of plasma factor XIII (a2b2 tetramer) by approximately 100-fold. In the presence of fibrin, the amount of gamma-thrombin required for activation was not affected. Catalytically inactive i-Pr2P- and D-Phe-Pro-Arg-CH2-alpha-thrombin were found to inhibit over 95% of the activation by alpha-thrombin in the presence of fibrin. Unlike plasma factor XIII, the concentration of alpha-thrombin required for 50% activation of platelet factor XIII (a2 dimer) was lower, and the activation was not enhanced by fibrin. However, when the a2 platelet factor XIII was incubated with purified b-chains, the alpha- and gamma-thrombin concentrations required for activation increased tenfold and reached levels similar to those required for activation of the plasma factor XIII. When fibrin was present, the alpha-thrombin concentrations needed for activation of the a2b2 complexes were reduced, and the presence of fibrin had no effect on gamma-thrombin cleavage of the a2b2 complexes. Therefore, the b-chains must inhibit a-chain cleavage by alpha-thrombin in the absence of fibrin. These results imply that the formation of a cocomplex involving alpha-thrombin, fibrin, and plasma factor XIII causes some conformational change in plasma factor XIII such that the b-chains no longer inhibit cleavage of the a-chains.
D005176:Factor XIII / Q000096:biosynthesis* / Q000378:metabolism; D005337:Fibrin / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D011485:Protein Binding; D011487:Protein Conformation; D013917:Thrombin / Q000378:metabolism* / Q000494:pharmacology; D011503:Transglutaminases
D005337:Fibrin; D005176:Factor XIII; D011503:Transglutaminases; D013917:Thrombin